Lensar (LNSR) Capital Expenditures Growth (1y) (2020 - 2025)
Lensar (LNSR) Capital Expenditures Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | -6.52% |
| 10 | Lensar | 104.16 Mn | 90.59 Mn | 9.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 185.19% |
| Mar 31, 2025 | -94.34% |
| Dec 31, 2024 | -93.33% |
| Sep 30, 2024 | 900.00% |
| Jun 30, 2024 | -85.08% |
| Mar 31, 2024 | 1,225.00% |
| Dec 31, 2023 | -21.05% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 1,710.00% |
| Mar 31, 2023 | -82.61% |
| Dec 31, 2022 | -63.46% |
| Sep 30, 2022 | -98.64% |
| Jun 30, 2022 | 115.87% |
| Mar 31, 2022 | -59.65% |
| Dec 31, 2021 | 48.57% |
| Sep 30, 2021 | 2,350.00% |
| Jun 30, 2021 | -141.45% |
| Mar 31, 2021 | 10.68% |
| Dec 31, 2020 | 47.89% |